Connect with us

Acorda Therapeutics Debuts Art Exhibition Inspired by People with Parkinson’s at the 5th World Parkinson Congress

Avatar

Published

on

Reading Time: 4 minutes

  • Framing OFF Through Art℠ gallery illustrates individuals’
    experience with OFF periods
  • New research on OFF periods to be presented at conference plenary
    session

ARDSLEY, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that it will
debut an art gallery inspired by people with Parkinson’s (PwP) at the 5th
World Parkinson Congress (WPC) in Kyoto, Japan. The six pieces of art,
ranging from acrylic sculptures to oil paintings, are the centerpiece of
Acorda’s Framing
OFF Through Art
initiative. OFF periods are the re-emergence of
Parkinson’s symptoms, and affect approximately 40 percent of the one
million people living with Parkinson’s in the U.S. This initiative
builds on Acorda’s “Live Well. Do Tell.℠” program; its goal is to help
initiate effective conversations about OFF periods between PwPs and
their healthcare professionals.

Framing OFF Through Art uses the power of art to help PwPs better
identify and articulate their experiences with OFF periods. It includes
a series of artworks inspired by the personal stories of people with
Parkinson’s and their care partners. The artworks were created by
artists who also have a personal connection to the disease. Conference
attendees can view the gallery and learn more at Acorda’s booth, #209.

“Research has consistently shown that OFF periods are among the most
common issues for people living with Parkinson’s disease,” said Ron
Cohen, M.D., Acorda’s President and CEO. “This re-emergence of
Parkinson’s symptoms can occur unexpectedly, up to several times a day,
despite daily medication regimens; this causes enormous disruption and
distress to the people who experience this. In addition, each person’s
experience with OFF periods is unique and can be difficult to describe.
We believe that people with Parkinson’s will be able to see aspects of
their own experiences with Parkinson’s and OFF periods in these works of
art, and use this as an opportunity to discuss their symptoms with their
healthcare team.”

In addition, new research on the nature and diversity of Parkinson’s
disease will be presented by Connie Marras, M.D., Ph.D., associate
professor at University Health Network, University of Toronto, during
the Morning Plenary on June 6, 2019, at 9:30 am JST. Dr. Marras will
also be presenting research around OFF periods during the poster tour on
June 5, 2019. The research on OFF periods was supported by an Acorda
Therapeutics research grant, administered by The Michael J. Fox
Foundation for Parkinson’s Research.

Acorda is also a gold sponsor of the WPC
2019 Art Walk
– a series of art, live music and dance exhibits. One
of these exhibits, “Soaring with Hope for PD,” features an installation
of 15,000 origami cranes with messages of hope from 39 countries.

About “Live Well. Do Tell.”

“Live Well. Do Tell.” is an initiative created by Acorda with input from
a multi-disciplinary Steering Committee of Parkinson’s community
leaders. The goal of the program is to develop tools to address
communication gaps among people with Parkinson’s, their care partners
and their healthcare professionals.

The Steering Committee included people with Parkinson’s, care partners,
movement disorder specialists, a nurse practitioner and representatives
from key advocacy groups, including the American Parkinson’s Disease
Association, Caregiver Action Network, Davis Phinney Foundation, The
Michael J. Fox Foundation, Parkinson’s Foundation, the Parkinson &
Movement Disorder Alliance and the World Parkinson Coalition.

For more information about “Live Well. Do Tell.” and Framing OFF
Through Art,
visit LiveWellDoTell.org.

About Parkinson’s and OFF Periods

Parkinson’s is a progressive neurodegenerative disorder resulting from
the gradual loss of certain neurons. These neurons are responsible for
producing dopamine and that loss causes a range of symptoms including
impaired movement, muscle stiffness and tremors. As Parkinson’s
progresses, people are likely to experience OFF periods, which are
characterized by the return of Parkinson’s motor and non-motor symptoms;
these can occur even in the presence of regular maintenance therapy.
Approximately one million people in the U.S. and 10 million people
worldwide are living with Parkinson’s; approximately 40 percent of
people with Parkinson’s in the U.S. are estimated to experience OFF
periods.

About Acorda Therapeutics

Acorda Therapeutics develops therapies to restore function and improve
the lives of people with neurological disorders. For more information on
Acorda products and pipeline, visit: https://www.acorda.com/products.

Forward-Looking Statement

This press release includes forward-looking statements. All statements,
other than statements of historical facts, regarding management’s
expectations, beliefs, goals, plans or prospects should be considered
forward-looking. These statements are subject to risks and uncertainties
that could cause actual results to differ materially, including: we may
not be able to successfully market Inbrija or any other products under
development; risks associated with complex, regulated manufacturing
processes for pharmaceuticals, which could affect whether we have
sufficient commercial supply of Inbrija to meet market demand; third
party payers (including governmental agencies) may not reimburse for the
use of Inbrija or our other products at acceptable rates or at all and
may impose restrictive prior authorization requirements that limit or
block prescriptions; competition for Inbrija, Ampyra and other products
we may develop and market in the future, including increasing
competition and accompanying loss of revenues in the U.S. from generic
versions of Ampyra (dalfampridine) following our loss of patent
exclusivity; the ability to realize the benefits anticipated from
acquisitions, among other reasons because acquired development programs
are generally subject to all the risks inherent in the drug development
process and our knowledge of the risks specifically relevant to acquired
programs generally improves over time; we may need to raise additional
funds to finance our operations and may not be able to do so on
acceptable terms; the risk of unfavorable results from future studies of
Inbrija (levodopa inhalation powder) or from our other research and
development programs, or any other acquired or in-licensed programs; the
occurrence of adverse safety events with our products; the outcome (by
judgment or settlement) and costs of legal, administrative or regulatory
proceedings, investigations or inspections, including, without
limitation, collective, representative or class action litigation;
failure to protect our intellectual property, to defend against the
intellectual property claims of others or to obtain third party
intellectual property licenses needed for the commercialization of our
products; and failure to comply with regulatory requirements could
result in adverse action by regulatory agencies.

These and other risks are described in greater detail in our filings
with the Securities and Exchange Commission. We may not actually achieve
the goals or plans described in our forward-looking statements, and
investors should not place undue reliance on these statements.
Forward-looking statements made in this press release are made only as
of the date hereof, and we disclaim any intent or obligation to update
any forward-looking statements as a result of developments occurring
after the date of this press release.

Contacts

MEDIA:
Tierney Saccavino
(914) 326-5104
tsaccavino@acorda.com

INVESTOR RELATIONS:
Felicia Vonella
(914) 326-5146
fvonella@acorda.com

Cannabis

PURA Cannabis Cultivation Spinoff and Dividend Breaking News Update

Newsfile

Published

on

Dallas, Texas–(Newsfile Corp. – July 10, 2020) – Puration, Inc. (OTC Pink: PURA) now has the following update to the press release published this morning about the management buyout of a separate public company that will in turn purchase PURA’s cannabis cultivation spinoff in exchange for common stock scheduled to close today. The management buyout has been executed by all parties. The purchase is scheduled to be funded on Monday. The management/owner team plans to make a formal announcement on Tuesday, July 14, 2020 (the formal announcement was previously expected on Monday, but to ensure funding is complete first, the announcement is now scheduled for the next day).

Cannot view this image? Visit: https://i1.wp.com/grassnews.net/wp-content/uploads/2020/07/pura-cannabis-cultivation-spinoff-and-dividend-breaking-news-update.jpg?w=740&ssl=1

PURA – Logo

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6696/59533_f41dea8d94434bba_001full.jpg

The common stock issued in exchange for the PURA spinoff is intended to be issued to PURA shareholders in a dividend distribution.

NCM Biotech, a subsidiary of Kali-Extracts (OTC Pink: KALY) will also be acquired and merged with PURA’s cannabis spinoff.

The management team purchasing control of the target public company is expected to confirm the planned acquisitions of PURA’s cannabis cultivation company and KALY’s NCM Biotech in the announcement now scheduled for Tuesday, July 14, 2020.

PURA’s cannabis cultivation operation is thriving. The operation has recently purchased and relocated to a new property from its former leased property. Texas lawmakers have recently implemented hemp friendly farming regulations and in so doing, universities within the State of Texas have initiated hemp farming research programs. PURA’s cannabis cultivation spinoff has initiated a number of joint research applications with Texas universities.

NCM Biotech is focused on medical research and the development of treatments derived from its patented cannabis extraction process. See a recent research report on CBD extracts derived from NCM Biotech’s patented extraction process: Journal of Cannabis Research.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59533

Continue Reading

Cannabis

PURA Ongoing EVERx CBD Sports Water Sales Fuel Expansion

Newsfile

Published

on

Dallas, Texas–(Newsfile Corp. – July 10, 2020) – Puration, Inc. (OTC Pink: PURA) management today indicated that its EVERx CBD Sports Water sales remain strong and continue to support the company’s expansion plans to diversify into additional CBD infused consumer product lines.

Cannot view this image? Visit: https://i0.wp.com/grassnews.net/wp-content/uploads/2020/07/pura-ongoing-everx-cbd-sports-water-sales-fuel-expansion.jpg?w=740&ssl=1

PURA – EVERx CBD Sports Water
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6696/59529_f20d25cae4a25bb8_001full.jpg

After launching an acquisition campaign in January, PURA has acquired four businesses ranging from CBD confections, to CBD pet products, to CBD sun care products and CBD sexual wellness products. PURA is building a brand name strategy to relaunch the acquired products. Management emphasizes that PURA’s success with EVERx CBD Sports Water is the ongoing catalyst making PURA’s diversified expansion possible.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59529

Continue Reading

Cannabis

SLANG Worldwide Announces Election of New Directors

Newsfile

Published

on

Toronto, Ontario–(Newsfile Corp. – July 10, 2020) – SLANG Worldwide Inc. (CNSX: SLNG) (“SLANG” or the “Company“), a leading global cannabis consumer packaged goods (CPG) company with a diversified portfolio of popular brands, today announced the election of four new directors who will add considerable expertise in consumer products, marketing, corporate strategy and financial management to its Board.

Joining SLANG’s Board are the following individuals:

  • Chris Donnelly is the founder of four start-up ventures across consumer products, digital marketing, and outdoor advertising. In 2002, Mr. Donnelly helped create the subsidiaries group within Nike. In 2006, Mr. Donnelly joined Oakley as SVP of Global Strategy and Product, where he rebuilt the organizational structure for all 3,000 employees to align the company around its top priorities. Over 9 years, through 450 new retail stores and 4 website launches, he shifted the direct to consumer business from 11% of revenues to 48%. Since 2016, Mr. Donnelly has spent his time advising and investing in consumer businesses.

  • Kelly Ehler is a Chartered Accountant and former auditor with PWC and banker with Bank of Montreal. He has sat on various public company corporate boards and board committees including additional roles as Audit Committee chair. He has led several companies, from start-ups to billion-dollar public companies, as CFO in a variety of industries and countries. His experience covers debt financing, due diligence, acquisitions and dispositions, audits, consolidations, multi jurisdiction entities and multijurisdictional public companies. Mr. Ehler also serves as CFO of SLANG.

  • Matt Fraser is President and COO at CANarchy Craft Brewery Collective (“CANarchy”) where he leads all business operations across the portfolio of craft breweries. Under his leadership, CANarchy has grown to the 8th largest craft brewery in the United States and operates 8 manufacturing locations and 16 brewpubs and taprooms. He initially joined CANarchy as CFO, with responsibility for financial reporting and analysis, forecasting and overall budget management. Mr. Fraser previously spent eight years at Lazard Frères in its Middle Market advisory group.

  • Robert (Bob) Verdun specializes in helping businesses with their go to market/growth strategies and effective ways to maximize shareholder value. He has recently been involved in dozens of M&A transactions, advising company owners on strategies for growth, acquisitions, mergers and capital raises. As President and Chief Executive Officer of Computerized Facility Integration, Mr. Verdun established partnerships with some of the leading companies in its industry and became IBM’s largest global partner for multiple product lines.

“We are very pleased to welcome four new directors with tremendous experience leading and counseling growth companies across a range of sectors. Their insights will be valuable as SLANG continues to execute on its vision of becoming the leading CPG company in the cannabis space,” said SLANG Chairman and CEO Peter Miller. “On behalf of the Company, I would also like to thank Chris McElvany, William Stocks and Olaf van Tulder for their contributions to our Board during the crucial early stages of our growth.”

All seven of the nominees listed in the Management Information Circular dated June 9, 2020 were elected as directors of the Company at its annual and special meeting of shareholders held in a virtual format on July 8, 2020. Re-elected directors include Chris Driessen, Peter Miller and Keith Stein. Messrs. Donnelly, Fraser, Stein and Verdun are all considered independent directors of the Company.

Media and Investor inquiries

Investors@SLANGworldwide.co

About SLANG Worldwide Inc.

SLANG Worldwide Inc. is a global leader in the cannabis CPG sector with a diversified portfolio of popular brands distributed across the United States. The Company specializes in acquiring and developing market-proven regional brands as well as launching innovative new brands to seize global market opportunities. SLANG is listed on the Canadian Securities Exchange under the ticker symbol SLNG. For more information, please visit www.slangww.com.

Forward-Looking Statements

This news release contains statements that constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur.

Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management of SLANG at this time, are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that could cause actual results to differ materially from those expressed or implied in such statements. Investors are cautioned not to put undue reliance on forward-looking statements. Applicable risks and uncertainties include, but are not limited to regulatory risks, risks related to the COVID-19 global pandemic, changes in laws, resolutions and guidelines, market risks, concentration risks, operating history, competition, the risks associated with international and foreign operations and the other risks identified under the headings “Risk Factors” in SLANG’s final long form prospectus dated January 17, 2019 and “Risks and Uncertainties” in the management discussion and analysis for the year ended December 31, 2019, as filed on SEDAR at www.sedar.com. SLANG is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59516

Continue Reading

Trending Online

Grassnews is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Grassnews digests / hand picks the latest news about the CBD / Legal Cannabis industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Grassnews .com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania